Bina Choi researches quantitative interstitial abnormalities and their relationship to acute respiratory disease events in people with a history of smoking.[9]
Bina Choi is identified with an M.D. credential.
Current relationship
Bina Choi, MD is a pulmonary and critical care physician-researcher focused on detecting early lung injury before it progresses to severe disease. She has been identified as an associate physician in the Division of Pulmonary and Critical Care Medicine at Brigham and Women’s Hospital and as a postdoctoral fellow at Harvard Medical School’s Applied Chest Imaging Laboratory. Earlier, she was identified as a Stanford medical student and later as a Pulmonary & Critical Care Fellow at Brigham and Women’s Hospital. Her research examines quantitative interstitial abnormalities on chest CT and their links to acute respiratory events, fibrosis, emphysema, and mortality, using biomarkers, computational biology, imaging, and proteomics. She has also received an ACRC Early Career Investigator grant award and authored patient education on pulmonary fibrosis.
Each topic is linked to its supporting source in Sources.
Training includes Bina Choi is identified with an M.D. credential., Bina Choi is identified as a postdoctoral fellow at the Applied Chest Imaging Laboratory, Harvard Medical School in Boston., Bina Choi is identified as a Pulmonary & Critical Care Fellow at Brigham and Women's Hospital; the article was last updated May 28, 2024., and Bina Choi was a Pulmonary & Critical Care Fellow at Brigham and Women's Hospital., plus 1 more record.
Explore education and trainingBina Choi researches quantitative interstitial abnormalities and their relationship to acute respiratory disease events in people with a history of smoking.[9]
Bina Choi's listed research diseases include COPD, emphysema, interstitial lung disease, and pulmonary fibrosis.[11]
Bina Choi's listed research topics include biomarkers, clinical research, computational biology, imaging radiology, and proteomics.[11]
Bina Choi's research project concerns proteomics signatures of quantitative interstitial abnormalities and impaired respiratory health.[11]
Her project reported 144 biomarkers associated with quantitative interstitial abnormalities, with similar effects observed in COPDGene and CARDIA.[11]